| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3354 | |||||||||||||||||||||||
| Submitter : | Mr. Thomas Barsella | Date & Time: | 12/15/2006 08:12:37 | |||||||||||||||||||||
| Organization : | Mr. Thomas Barsella | |||||||||||||||||||||||
| Category : | Drug Industry | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I agree with the FDA's proposition to turn aborted fetal cells in to viral vaccines, if it will help the majority of people. | ||||||||||||||||||||||||